About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease

NCT07680335·8 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Floor Duits, PhD
CONTACT
020 - 4440816 f.duits@amsterdamumc.nl

Lead

Alzheimercentrum Amsterdam

With

Davos Alzheimer's Collaborative
Quanterix Corporation (in kind)

Age

55–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patient presents in memory clinic with cognitive complaints.
The physician is concerned about underlying AD as etiology of the complaints.
Adequate fluency in Dutch to understand informed consent procedure.

You may not be if

Age under 55.
Previous biomarker-confirmed diagnosis of AD.
Alcohol or drug abuse to such an extent that treatment would be advisable.
Patient is incapacitated, and is not able to judge consequences of participation.

The record

StatusRecruiting

PhaseNot applicable

Taking part550

StartedSep 2025

UpdatedJul 2, 2026

Conditions

Alzheimer Blood Biomarkers Alzheimer's Disease (AD)

Where8

Amsterdam UMC
Amsterdam, North Holland, Netherlands
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
Flevoziekenhuis
Almere Stad, Netherlands